| ID | Sequence | Length | GC content |
|---|---|---|---|
| LINC01419:1 | CGCUCGGGUCCCCUUCCACAUCGUGGAAGCUUUGUUCUUUCGCUCUUUG… | 1027 nt | 0.4265 |
| LINC01419:2 | CCUUCCACAUCGUGGAAGCUUUGUUCUUUCGCUCUUUGCAAUAAAUCUU… | 1551 nt | 0.3798 |
| LINC01419:3 | CUUCCACAUCGUGGAAGCUUUGUUCUUUCGCUCUUUGCAAUAAAUCUUG… | 1516 nt | 0.3813 |
| LINC01419:4 | CUUCCACAUCGUGGAAGCUUUGUUCUUUCGCUCUUUGCAAUAAAUCUUG… | 1521 nt | 0.3800 |
| LINC01419:5 | CUUCCACAUCGUGGAAGCUUUGUUCUUUCGCUCUUUGCAAUAAAUCUUG… | 1518 nt | 0.3808 |
| LINC01419:6 | GGUCCUUUCAUUUUAUAAAUUAGACCUGAUAUUCCCUGUGUUCUUCAAA… | 1480 nt | 0.3405 |
No relevant information is available at the moment.
A study in human and mouse models demonstrated that LINC01419 is upregulated in liver tissues and is involved in cell cycle regulation, contributing to proliferation in hepatocellular carcinoma [Machida et al. DOI:10.1016/J.Cbi.2020.109055].